Diagnosis and antibiotic treatment of reactive arthritis;Diagnostik und antibiotische therapie bei reaktiver arthritis

Deutsche Medizinische Wochenschrift

Volumn 127, Issue 37, 2002, Pages 1893-1896

  Sieper, Joachim ^a   Braun, J ^a  

^a U Klin B F Med Klin I Rheum   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CHLAMYDIA; HUMAN; REACTIVE ARTHRITIS; SALMONELLA; YERSINIA;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIBODIES, BACTERIAL; ARTHRITIS, REACTIVE; AZITHROMYCIN; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CIPROFLOXACIN; CLINICAL TRIALS; DIAGNOSIS, DIFFERENTIAL; DNA, BACTERIAL; DRUG THERAPY, COMBINATION; ENTERITIS; FEMALE; HUMANS; MALE; MODELS, THEORETICAL; POLYMERASE CHAIN REACTION; RIFAMPIN; SALMONELLA; SALMONELLA INFECTIONS; SENSITIVITY AND SPECIFICITY; TETRACYCLINES; TIME FACTORS; URETHRITIS; UTERINE CERVICITIS; YERSINIA; YERSINIA INFECTIONS;

EID: 0037072997     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-34068     Document Type: Article

References (24)

1. Bardin T, Enel C, Cornelis F, Salski C, Jorgensen C, Ward R, Lathrop GM. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. Arthritis Rheum 1992 Feb; 35: 190-194
2. Bas S, Griffais R, Kvien TK, Glennås A, Melby K, Vischer TL. Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum 1995; 38: 1005-1013
3. Bas S, Ninet B, Delaspre O, Vischer TL. Evaluation of commercially available tests for Chlamydia nucleic acid detection in synovial fluid of patients. Br J Rheumatol 1997; 36: 198-202
4. Bas S, Vischer TL. Chlamydia trachomatis antibody detection and diagnosis of reactive arthritis. Br J Rheumatol 1998; 37: 1054-1059
5. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34: 218-1227
6. Dreses-Werringloer U, Padubrin I, Jurgens-Saathoff B, Hudson AP, Zeidler H, Kohler L. Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro. Antimicrob Agents Chemother 2000; 44: 3288-3289
7. Dreses-Werringloer U, Padubrin I, Zeidler H, Kohler L. Effects of azithromycin and rifampicin on Chlamydia trachomatis infection in vitro. Antimicrob Agents Chemother 2001; 45: 3001-3008
8. El-Gabalawy HS, Goldbach-Mansky R, Smith D2nd, Arayssi T, Bale S, Gulko P et al. Association of HLA alleles and clinical features in patients with synovitis of recent onset. Arthritis Rheum 1999; 42: 1696-1705
9. Fendler C, Leiko S, Sorensen H, Gripenberg-Lerce C, Groh A, Uksila J, Granfors K, Braun J, Sieper J. Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis. Ann Rheum Dis 2001; 60: 377-343
10. Granfors K, Viljanen M, Tiilikainen A, Toivanen A. Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis. J Infect Dis 1980; 141: 424-429
11. Hoogkamp-Korstanje JA, Moesker H, Bruyn GA. Ciprofloxacin v placebo for treatment of Yersinia enterocolitica triggered reactive arthritis. Ann Rheum Dis 2000; 59: 914-917
12. Kuipers JG, Nietfeld L, Dreses-Werringloer U, Koehler K, Wollenhaupt J, Zeidler H et al. Optimised sample preparation of synovial fluid for detection of Chlamydia trachomatis DNA by polymerase chain reaction. Ann Rheum Dis 1999; 58: 103-108
13. Kvien TK, Glennås A, Melby K, Granfors K, Andrup O, Karstensen B et al. Reactive arthritis: incidence, triggering agents and clinical presentation. J Rheumatol 1994; 21: 115-122
14. Lauhio A, Leirisalo-Repo M, Lahdevirta J, Saikku P, Repo H. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 1991; 34: 6-14
15. Locht H, Kihlstrom E, Lindstrom FD. Reactive arthritis after Salmonella among medical doctors - study of an outbreak. J Rheumatol 1993; 20: 845-848
16. Mattila L, Leirisalo-Repo M, Pelkonen P, Koskimies S, Granfors K, Siitonen A. Reactive arthritis following an outbreak of Salmonella Bovismorbificans infection. J Infect 1998; 36: 289-295
17. Rabenau H, Berger A, Doerr HW, Weber B. Testing for Chlamydia trachomatis in urine. Lancet 1997; 349: 1024-1025
18. Sieper J, Braun J, Brandt J, Miksits K, Heesemann J, Laitko S et al. Pathogenetic role of Chlamydia, Yersinia and Borrelia in undifferentiated oligoarthritis. J Rheumatol 1992; 19: 1236-1242
19. Sieper J, Fendler C, Laitko S, Sorensen H, Gripenberg-Lerche C, Hiepe F, Alten R, Keitel W, Groh A, Uksila J, Eggens U, Granfors K, Braun J. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study. Arthritis Rheum 1999; 42: 1386-1396
20. Sieper J, Rudwaleit M, Braun J, van der Heijde D. Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays. Arthritis Rheum 2002; 46: 319-327
21. Toivanen A, Yli-Kerttula T, Luukkainen R, Merilahti-Palo R, Granfors K, Seppala J. Effect of antimicrobial treatment on chronic reactive arthritis. Clin Exp Rheumatol 1993; 11: 301-307
22. Wilkens RF. Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Arthritis Rheum 1981; 24: 844-849
23. Yli-Kerttula T, Luukkainen R, Yli-Kerttula U, Mottonen T, Hakola M, Korpela M, Sanila M, Parviainen J, Uksila J, Vainionpaa R, Toivanen A. Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis. Ann Rheum Dis 2000; 59: 565-570
24. Zhang Y, Gripenberg-Lerche C, Soderstrom KO, Toivanen A, Toivanen P. Antibiotic prophylaxis and treatment of reactive arthritis. Lessons from an animal model. Arthritis Rheum 1996; 39: 1238-1243